Suggestions
Shimon Eckhouse
Co-Founder and Chairman of the Board at Epitomee Medical, SofWave, Rapid Medical, Alon-Medtech Ventures
Shimon Eckhouse is a prominent figure in the medical device industry, serving as the Co-founder and Chairman of the Board at HALLURA. He is an accomplished inventor, investor, and active entrepreneur with a focus on medical devices and medical technologies.1
Professional Background
Eckhouse's expertise spans various aspects of the medical device field. He has been involved in numerous ventures and innovations, demonstrating a keen interest in advancing healthcare technology. His LinkedIn profile showcases his involvement in multiple companies and projects within the medical sector.
Notable Achievements
Entrepreneurial Ventures: Eckhouse has been associated with several successful medical device companies. One such company is Rapid Medical, which he frequently mentions in his LinkedIn posts. Rapid Medical is known for developing innovative thrombectomy devices, including:
- The world's only adjustable thrombectomy device, which recently gained approval in China3
- TIGER, a device showcased at medical conferences like SNIS20235
Industry Impact: Eckhouse's contributions to the medical device industry in Israel are significant. He has highlighted how Israeli medical device companies continue to operate and save lives globally, even during challenging times.2
Educational Background
Shimon Eckhouse received his education from the University of California1, though the specific field of study is not mentioned in the provided search results.
Current Interests
Eckhouse remains actively engaged in the medical technology sector. He frequently shares updates about:
- Medical device innovations
- Industry conferences and events, such as ICI in Tel-Aviv4
- Advancements in various medical fields, including neurovascular interventions and aesthetic medicine6
Through his LinkedIn posts, Shimon Eckhouse demonstrates a continued passion for medical innovation and a commitment to improving healthcare through technology.
Highlights
Exciting news in endo-vascualr brain treatment! The FDA has recently cleared the DRIVEWIRE™ 24, an innovative endovascular navigation device that revolutionizes the treatment of ischemic strokes and brain aneurysms. This groundbreaking technology allows for precise navigation of devices in the brain, and in treatment of peripheral vascular diseases leading to more effective, faster and accurate procedures. Clinicians can now provide better outcomes for patients with these critical conditions. The first clinical use of the DRIVEWIRE™ 24 following its FDA clearance marks a significant milestone in neurovascular interventional treatments, showcasing how advanced tools developed by Rapid Medical are shaping the future of medical treatment.
Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution | Business Wire
ICI is happening in Tel-Aviv, come and join us in the most energetic and innovative gathering of clinicians, scientist and industry
